Lebwohl David

EVP, Chief Medical Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

+17.5%

Avg 12M Return

+53.7%

Lebwohl David is an EVP, Chief Medical Officer at Intellia Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.

Estimated insider holdings value: $1.7M based on current market prices.

Holdings by Company

NTLAJan 5, 2026

Current Shares121.2K

Value$1.71M

Net Activity-42,928

Bought: 0Sold: 42.9K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 5, 2026	NTLA Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	11,903	$9.21	$109,626.63	-8.9%	+41.9%	-
Jan 3, 2025	NTLA Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	9,557	$12.18	$116,404.26	-9.8%	-43.2%	-24.1%
Jan 3, 2024	NTLA Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	5,843	$29.46	$172,134.78	-9.7%	-14.9%	-58.6%
Jan 4, 2023	NTLA Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sell	2,574	$37.21	$95,778.54	-9.1%	-7.5%	-24.6%
Jan 1, 2022	NTLA Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sale+OE	1,051	$112.24	$117,964.24	-8.8%	-35.6%	-70.7%
Nov 5, 2021	NTLA Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sale+OE	2,400	$132.72	$318,534.60	-6.1%	-30.2%	-62.4%
Oct 14, 2021	NTLA Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sale+OE	2,400	$128.44	$308,249.11	-4.8%	-25.7%	-60.3%
Sep 21, 2021	NTLA Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sale+OE	2,400	$149.81	$359,544.00	-75.2%	-17.0%	-59.7%
Aug 30, 2021	NTLA Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sale+OE	2,400	$158.04	$379,300.00	-21.0%	-27.4%	-60.9%
Aug 9, 2021	NTLA Intellia Therapeutics, Inc.	EVP, Chief Medical Officer	Sale+OE	2,400	$164.05	$393,720.00	-75.2%	-15.1%	-62.3%